Connor, Clark & Lunn Investment Management (CC&L)’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-63,605
Closed -$1.67M 680
2014
Q1
$1.67M Buy
+63,605
New +$1.67M 0.01% 296